• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

α-突触核蛋白磷酸化和截断是成人脑中的正常事件。

α-synuclein phosphorylation and truncation are normal events in the adult human brain.

机构信息

Institut de Neuropatologia, Servei Anatomia Patològica, IDIBELL-Hospital Universitari de Bellvitge, Hospitalet de LLobregat, CIBERNED, Instituto Carlos III, Barcelona, Spain.

出版信息

Neuroscience. 2012 Jan 3;200:106-19. doi: 10.1016/j.neuroscience.2011.10.042. Epub 2011 Oct 29.

DOI:10.1016/j.neuroscience.2011.10.042
PMID:22079575
Abstract

α-synuclein is a key protein in Lewy body diseases (LBDs) and a major component of Lewy bodies and related aberrant cytoplasmic and neuritic inclusions. Regional differences in α-synuclein have been associated with selective neuronal vulnerability to Lewy pathology. Furthermore, phosphorylation at serine 129 (Ser129) and α-synuclein truncation have been considered crucial in the pathogenesis of Lewy inclusions. The present study shows consistent reduction in α-synuclein protein expression levels in the human substantia nigra and nucleus basalis of Meynert compared with other brain regions independently of age and pathology. Phosphorylated α-synuclein at Ser129 is naturally increased in these same regions, thus inversely related with the total amount of α-synuclein. In contrast, truncated α-synuclein is naturally observed in control and diseased brains and correlating with the total amount of α-synuclein. Several truncated variants have been identified where some of these variants are truncated at the C-terminal domain, whereas others are truncated at the N-terminal domain, and all are present in cases with and without Lewy pathology. Although accumulation of truncated α-synuclein variants and phosphorylated α-synuclein occurs in Lewy bodies, α-synuclein phosphorylation and truncation can be considered constitutive in control and diseased brains.

摘要

α-突触核蛋白是路易体疾病(LBDs)的关键蛋白,也是路易体和相关异常细胞质和神经突包含物的主要成分。α-突触核蛋白的区域差异与路易病病理学对选择性神经元易感性有关。此外,丝氨酸 129(Ser129)的磷酸化和α-突触核蛋白截断被认为在路易包涵体的发病机制中至关重要。本研究显示,与其他脑区相比,人类黑质和梅内特基底核中的α-突触核蛋白表达水平一致降低,与年龄和病理学无关。在这些相同的区域,磷酸化的α-突触核蛋白 Ser129 自然增加,因此与α-突触核蛋白的总量呈负相关。相比之下,截断的α-突触核蛋白在对照和患病脑中自然存在,并与α-突触核蛋白的总量相关。已经鉴定出几种截断的变体,其中一些变体在 C 末端结构域截断,而另一些在 N 末端结构域截断,所有这些变体都存在于有或没有路易病病理学的病例中。尽管截断的α-突触核蛋白变体和磷酸化的α-突触核蛋白在路易体中积累,但α-突触核蛋白的磷酸化和截断可以被认为是对照和患病脑中的组成性。

相似文献

1
α-synuclein phosphorylation and truncation are normal events in the adult human brain.α-突触核蛋白磷酸化和截断是成人脑中的正常事件。
Neuroscience. 2012 Jan 3;200:106-19. doi: 10.1016/j.neuroscience.2011.10.042. Epub 2011 Oct 29.
2
Proteinase K-resistant alpha-synuclein is deposited in presynapses in human Lewy body disease and A53T alpha-synuclein transgenic mice.蛋白水解酶抗性的α-突触核蛋白在人类路易体病和 A53Tα-突触核蛋白转基因小鼠的突触前体中沉积。
Acta Neuropathol. 2010 Aug;120(2):145-54. doi: 10.1007/s00401-010-0676-z. Epub 2010 Mar 26.
3
Abundant neuritic inclusions and microvacuolar changes in a case of diffuse Lewy body disease with the A53T mutation in the alpha-synuclein gene.一例α-突触核蛋白基因存在A53T突变的弥漫性路易体病患者出现大量神经突包涵体和微空泡改变。
Acta Neuropathol. 2005 Sep;110(3):298-305. doi: 10.1007/s00401-005-1042-4. Epub 2005 Jun 25.
4
Relationship of phosphorylated alpha-synuclein and tau accumulation to Abeta deposition in the cerebral cortex of dementia with Lewy bodies.路易体痴呆患者大脑皮质中磷酸化α-突触核蛋白和tau蛋白积累与β-淀粉样蛋白沉积的关系。
Exp Neurol. 2008 Apr;210(2):409-20. doi: 10.1016/j.expneurol.2007.11.019. Epub 2007 Dec 3.
5
Nuclear and neuritic distribution of serine-129 phosphorylated alpha-synuclein in transgenic mice.丝氨酸129磷酸化α-突触核蛋白在转基因小鼠中的细胞核及神经突分布
Neuroscience. 2009 Jun 2;160(4):796-804. doi: 10.1016/j.neuroscience.2009.03.002. Epub 2009 Mar 9.
6
Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.在帕金森病早期,α-突触核蛋白重新分布至黑质中的神经黑素脂质。
Brain. 2005 Nov;128(Pt 11):2654-64. doi: 10.1093/brain/awh584. Epub 2005 Jul 6.
7
Patterns of protein nitration in dementia with Lewy bodies and striatonigral degeneration.路易体痴呆和纹状体黑质变性中蛋白质硝化模式。
Acta Neuropathol. 2002 May;103(5):495-500. doi: 10.1007/s00401-001-0495-3. Epub 2002 Feb 23.
8
alpha-Synuclein is colocalized with 14-3-3 and synphilin-1 in A53T transgenic mice.在A53T转基因小鼠中,α-突触核蛋白与14-3-3和突触结合蛋白-1共定位。
Acta Neuropathol. 2006 Dec;112(6):681-9. doi: 10.1007/s00401-006-0132-2. Epub 2006 Sep 7.
9
Accumulation of phosphorylated alpha-synuclein in the brain and peripheral ganglia of patients with multiple system atrophy.多系统萎缩患者大脑和外周神经节中磷酸化α-突触核蛋白的积累。
Acta Neuropathol. 2004 Apr;107(4):292-8. doi: 10.1007/s00401-003-0811-1. Epub 2004 Jan 14.
10
Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease.大鼠黑质中α-突触核蛋白的过表达导致多巴胺能神经元丧失、α-突触核蛋白磷酸化及半胱天冬酶-9激活:类似于帕金森病的致病变化。
J Neurochem. 2004 Oct;91(2):451-61. doi: 10.1111/j.1471-4159.2004.02728.x.

引用本文的文献

1
Differential role of C-terminal truncations on alpha-synuclein pathology and Lewy body formation.α-突触核蛋白C末端截短在病理学及路易小体形成中的不同作用
NPJ Parkinsons Dis. 2025 Aug 26;11(1):261. doi: 10.1038/s41531-025-01084-y.
2
c-Abl Inhibitors in Parkinson's: Exploring Hypotheses on Alpha-Synuclein Modulation.帕金森病中的c-Abl抑制剂:探索α-突触核蛋白调节假说
Adv Pharm Bull. 2025 Feb 9;15(1):7-10. doi: 10.34172/apb.42806. eCollection 2025 Apr.
3
Current strategies in the management of dementia with lewy bodies and future directions based on disease pathophysiology.
路易体痴呆的当前管理策略及基于疾病病理生理学的未来方向。
Mol Neurodegener. 2025 Jul 1;20(1):78. doi: 10.1186/s13024-025-00856-7.
4
Immunization targeting diseased proteins in synucleinopathy and tauopathy: insights from clinical trials.针对突触核蛋白病和tau蛋白病中患病蛋白的免疫疗法:来自临床试验的见解
Transl Neurodegener. 2025 Jul 1;14(1):33. doi: 10.1186/s40035-025-00490-9.
5
Monomers, Dimers, and Oligomers of Pyroglutamate-Modified α-Synuclein Fragments Exhibit Distinct Biophysical Characteristics.焦谷氨酸修饰的α-突触核蛋白片段的单体、二聚体和寡聚体表现出不同的生物物理特性。
ACS Chem Neurosci. 2025 May 21;16(10):1919-1936. doi: 10.1021/acschemneuro.5c00106. Epub 2025 Apr 30.
6
Alpha-Synuclein Pathophysiology in Neurodegenerative Disorders: A Review Focusing on Molecular Mechanisms and Treatment Advances in Parkinson's Disease.神经退行性疾病中的α-突触核蛋白病理生理学:聚焦帕金森病分子机制与治疗进展的综述
Cell Mol Neurobiol. 2025 Mar 26;45(1):30. doi: 10.1007/s10571-025-01544-2.
7
Motor deficits and brain pathology in the Parkinson's disease mouse model hA53Ttg.帕金森病小鼠模型hA53Ttg中的运动功能障碍与脑病理学
Front Neurosci. 2024 Sep 20;18:1462041. doi: 10.3389/fnins.2024.1462041. eCollection 2024.
8
Posttranslational Modifications of -Synuclein, Their Therapeutic Potential, and Crosstalk in Health and Neurodegenerative Diseases.- 突触核蛋白的翻译后修饰、它们的治疗潜力,以及在健康和神经退行性疾病中的相互作用。
Pharmacol Rev. 2024 Oct 16;76(6):1254-1290. doi: 10.1124/pharmrev.123.001111.
9
Therapeutic Implications and Regulations of Protein Post-translational Modifications in Parkinsons Disease.帕金森病中蛋白质翻译后修饰的治疗意义和调控。
Cell Mol Neurobiol. 2024 Jul 3;44(1):53. doi: 10.1007/s10571-024-01471-8.
10
Physiological roles of α-synuclein serine-129 phosphorylation - not an oxymoron.α-突触核蛋白丝氨酸 129 磷酸化的生理作用——并非矛盾。
Trends Neurosci. 2024 Jul;47(7):480-490. doi: 10.1016/j.tins.2024.05.005. Epub 2024 Jun 10.